Clinical Trial Update: Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk [NA]

View source ↗

Summary

This trial update announces expansion of the HighLife 28mm trans-septal trans-catheter mitral valve study to include more patients at high surgical risk with mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• HighLife 28mm Trans-septal Trans-catheter Mitral Valve

Snippet

Sponsor: HighLife SAS | Conditions: Mitral Regurgitation | NA | Status: RECRUITING